The recent epidemics of metabolic diseases, obesity, type 2 diabetes(T2D), liver lipid disorders and metabolic syndrome have largely been attributed to genetic background and changes in diet, exercise and aging. However, there is now considerable evidence that other environmental factors may contribute to the rapid increase in the incidence of these metabolic diseases. This review will examine changes to the incidence of obesity, T2D and non-alcoholic fatty liver disease (NAFLD), the contribution of genetics to these disorders and describe the role of the endocrine system in these metabolic disorders. It will then specifically focus on the role of endocrine disrupting chemicals (EDCs) in the etiology of obesity, T2D and NAFLD while finally integrating the information on EDCs on multiple metabolic disorders that could lead to metabolic syndrome. We will specifically examine evidence linking EDC exposures during critical periods of development with metabolic diseases that manifest later in life and across generations.

Metabolism disrupting chemicals and metabolic disorders

PANZICA, Giancarlo;
2017-01-01

Abstract

The recent epidemics of metabolic diseases, obesity, type 2 diabetes(T2D), liver lipid disorders and metabolic syndrome have largely been attributed to genetic background and changes in diet, exercise and aging. However, there is now considerable evidence that other environmental factors may contribute to the rapid increase in the incidence of these metabolic diseases. This review will examine changes to the incidence of obesity, T2D and non-alcoholic fatty liver disease (NAFLD), the contribution of genetics to these disorders and describe the role of the endocrine system in these metabolic disorders. It will then specifically focus on the role of endocrine disrupting chemicals (EDCs) in the etiology of obesity, T2D and NAFLD while finally integrating the information on EDCs on multiple metabolic disorders that could lead to metabolic syndrome. We will specifically examine evidence linking EDC exposures during critical periods of development with metabolic diseases that manifest later in life and across generations.
2017
68
3
33
http://www.sciencedirect.com/science/article/pii/S089062381630363X
Developmental origins of health and disease; Diabetes; Endocrine disruptors; Lipid disorders; Metabolism disruptors; Obesity; Obesogens
Heindel, Jerrold J; Blumberg, Bruce; Cave, Mathew; Machtinger, Ronit; Mantovani, Alberto; Mendez, Michelle A; Nadal, Angel; Palanza, Paola; Panzica, Giancarlo; Sargis, Robert; Vandenberg, Laura N; Vom Saal, Frederick
File in questo prodotto:
File Dimensione Formato  
2017HeindelReprTox.pdf

Accesso riservato

Descrizione: 2017HeindelReprTox.pdf
Tipo di file: PDF EDITORIALE
Dimensione 6.45 MB
Formato Adobe PDF
6.45 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
2016HeindelReprTox-MS_4aperto.pdf_4aperto.pdf

Open Access dal 02/03/2018

Descrizione: 2017HeindelReprTox-aperto-pdf
Tipo di file: POSTPRINT (VERSIONE FINALE DELL’AUTORE)
Dimensione 1.51 MB
Formato Adobe PDF
1.51 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1630432
Citazioni
  • ???jsp.display-item.citation.pmc??? 242
  • Scopus 693
  • ???jsp.display-item.citation.isi??? 623
social impact